image_pdfimage_print
18 01, 2023

HB 210

This bill requires the Health Data Committee to annually issue a report on primary care spending within the state, establish a plan for collecting data from data suppliers to determine measurements of cost and reimbursements for risk-adjusted episodes of health care; report on rate and price increases by health care providers; and publish an annual report on primary care spending within the state.

HB 210
18 01, 2023

HB 223

This bill creates price caps for certain diabetic supplies: requires a health benefit plan to cap the price of the insulin pumps; requires a health benefit plan to cap the price of the continuous blood glucose monitors

HB 223
15 12, 2022

Healthcare Consolidation Q4 2022: Cross-Market Mergers Continue Apace

2022 has been an active year in healthcare consolidation as well as for merger challenges and enforcement. As we approach the year end, healthcare deals continued as many entities seek to close the transactions before the new year. Increasingly, as seen in the 4th quarter, healthcare deals are shifting to cross-market transactions, making review and enforcement efforts more challenging. In case you missed it, this final Litigation and Enforcement Highlights of the year will help you catch up on some of the cross-market deals in Q4 2022 that caught our attention.   Advocate Aurora [...]

Healthcare Consolidation Q4 2022: Cross-Market Mergers Continue Apace
14 06, 2022

Q2 2022: Antitrust Enforcement Actions Flourish Against Healthcare Consolidation and Anticompetitive Contracting

It's been a busy month in healthcare antitrust land, both for federal regulators and private plaintiffs, as we saw an explosion of enforcement actions challenging both proposed mergers and anticompetitive conduct that stemmed from previous mergers. From New Jersey to Utah, large health systems such as HCA are being increasingly scrutinized and coming under fire for garnering and using their market power in anticompetitive ways.   Merger Challenges Fresh from its appeals court win in the Hackensack Meridian and Englewood merger challenge, the Federal Trade Commission (FTC) is continuing its momentum and kicking off [...]

Q2 2022: Antitrust Enforcement Actions Flourish Against Healthcare Consolidation and Anticompetitive Contracting
10 06, 2022

FTC v. HCA Healthcare & Steward Health Care

HCA Healthcare, the second largest health system with six hospitals in the Wasatch Front region of Utah, proposed to acquire five hospitals from Steward Health Care, the fourth largest system in the region.  According to the FTC, the two rival hospital systems vigorously compete with each other to keep costs down. The proposed merger is likely to substantially lessen competition for general acute care services in healthcare markets of at least four counties that are already high concentrated. Specifically, the merger would increase the Herfindahl-Hirschman Index (“HHI”) by more 200 points to 2,500, which [...]

FTC v. HCA Healthcare & Steward Health Care
2 06, 2022

HB 400

Associate Physician License Amendments. This bill repeals a restriction that an associate physician may only practice primary care services; and amends provisions relating to the collaborative practice arrangement for an associate physician.

HB 400